Annual report pursuant to Section 13 and 15(d)

6. Goodwill and Indefinite-Lived Intangible Assets

v3.8.0.1
6. Goodwill and Indefinite-Lived Intangible Assets
12 Months Ended
Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Indefinite-Lived Intangible Assets

Goodwill

 

A reconciliation of the change in the carrying value of goodwill is as follows:

 

Balance as of January 1, 2016   $ 3,283,379  
No changes      
Balance as of December 31, 2016   $ 3,283,379  
No changes      
Balance as of December 31, 2017   $ 3,283,379  

 

As of October 1, 2017 and 2016, the dates of the Company’s annual impairment review, the fair value of the Company’s goodwill balance exceeded its carrying value.

 

Indefinite-Lived Intangible Assets

 

The Company’s acquired indefinite-lived intangible asset, OncoHist, is IPR&D relating to the Company’s business combination with SymbioTec in 2012. The carrying value of OncoHist was approximately $9.2 million as of December 31, 2017 and 2016. No impairment was recorded during the years ended December 31, 2017 and 2016. OncoHist is not yet commercialized and, therefore, has not yet begun to be amortized as of December 31, 2017.